A share price of Cardlytics Inc [CDLX] is currently trading at $3.59, up 11.49%. An important factor to consider is whether the stock is rising or falling in short-term value. The CDLX shares have gain 9.12% over the last week, with a monthly amount drifted -0.28%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on October 11, 2024, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $4. Previously, Northland Capital downgraded its rating to Market Perform on August 16, 2024, and kept the price target unchanged to $5. On August 15, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $3.50 on the stock. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to a Hold and reduced its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to Hold for this stock on August 08, 2024.
Cardlytics Inc experienced fluctuations in its stock price throughout the past year between $2.89 and $20.52. Currently, Wall Street analysts expect the stock to reach $6.7 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $3.59 at the most recent close of the market. An investor can expect a potential return of 86.63% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
Trailing Twelve Months sales for Cardlytics Inc [NASDAQ:CDLX] were 305.42M which represents -9.21% decline. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.8 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.35 points at the first support level, and at 3.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.72, and for the 2nd resistance point, it is at 3.85.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cardlytics Inc [NASDAQ:CDLX] is 1.77. On the other hand, the Quick Ratio is 1.77, and the Cash Ratio is 0.68. Considering the valuation of this stock, the price to sales ratio is 0.59, the price to book ratio is 0.84.
Transactions by insiders
Recent insider trading involved DeSieno Alexis, Chief Financial Officer, that happened on Oct 02 ’24 when 7487.0 shares were sold. Chief Legal & Privacy Officer, Lynton Nicholas Hollmeyer completed a deal on Oct 02 ’24 to sell 5936.0 shares. Meanwhile, Chief Executive Officer Gupta Amit sold 7543.0 shares on Oct 02 ’24.
